0001). Naproxcinod 750 mg bid was noninferior to naproxen at weeks 13 and 26. Naproxcinod was well tolerated, with no notable differences in orthostatic blood pressure response between treatments.
Conclusion: Naproxcinod 750 mg bid and 375 mg bid demonstrated superior efficacy over placebo for treatment of OA and were well tolerated over 1 year. Naproxcinod 750 mg bid was noninferior to naproxen 500 mg bid. (C) 2011 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 40:285-297″
“We describe two balloon-assisted techniques to facilitate the advancement of large,
long sheaths through freshly placed find more stents or tortuous anatomy. The first technique uses a balloon inflated while partially housed within the sheath to help clear an edge, thus offering resistance. The second uses an angioplasty balloon inflated in a distal pulmonary artery branch to better anchor the wire while advancing the sheath through a tortuous path. The techniques are illustrated by the cases of four patients, including two undergoing Melody valve (Medtronic,
Minneapolis, MN) implantation.”
“Background: Neurologic involvement occurs in approximately 25% of patients with primary Sjogren’s syndrome. Manifestations are diverse and can affect the entire neuroaxis. Central nervous system dysfunction involves the brain as well as the spinal cord and may recur over time. Due to a variety of presentations, Sjogren’s syndrome with neurologic involvement may be difficult to diagnose.
Methods: We report 4 cases Rabusertib mouse of patients with primary Sjogren’s syndrome who presented with atypical neurologic manifestations.
Results: The first case describes a patient with a pseudotumoral lesion. The second patient was a 54-year-old woman suffering from a multiple mononeuropathy. The third case describes a 66-year-old man whose primary Sjogren’s Epigenetics inhibitor syndrome presented as progressive multiple sclerosis, and the fourth case reports a 57-year-old woman
patient suffering from myelitis along with progressive cognitive disorders.
Conclusions: Neurologic impairment in Sjogren’s syndrome is probably underestimated and the diagnosis is often delayed. Primary Sjogren’s syndrome should be suspected in patients presenting with atypical clinical and radiologic neurologic manifestations. (C) 2011 Elsevier Inc. All rights reserved. Semin Arthritis Rheum 40:338-342″
“This randomized trial compared physical activity enhancing exercise prescription and education programs in 61 children (36 male) with single-ventricle physiology after Fontan. After Fontan, children are less active than recommended for optimal health. They are often geographically dispersed and unable to attend weekday programs. Participants, 5.9-11.7 years of age who were status 5.3 years post-Fontan, received 12-month, parent-delivered home programs to enhance physical activity, motor skill, fitness, and activity attitudes. Daily moderate-to-vigorous physical activity (MVPA) was measured at baseline and again at 6, 12, and 24 months.